Hamilton Insurance Group Ltd
For the period ended Dec 31, 2023. Filed Mar 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 7, 2024
HG$38.82+3.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Years Ended · Month Ended · Year Ended | ||||
|---|---|---|---|---|
| December 31, · December 31, · November 30, | ||||
| ($ in thousands) | 2023 | 2022 | 2021 | 2021 |
| Operating activities | ||||
| Net income (loss) | $280,287 | $(29,935) | $(35,890) | $249,839 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||||
| Depreciation and amortization | 12,410 | 14,994 | 961 | 13,898 |
| Share compensation expense | 44,378 | 10,784 | 1,043 | 8,883 |
| Net realized (gains) losses on investments | (84,302) | (251,662) | (11,302) | (278,691) |
| Change in net unrealized (gains) losses on investments | (125,097) | 165,305 | 44,828 | (73,502) |
| Impairment of goodwill | — | 24,082 | — | 936 |
| Net gain on sale of equity method investment | (211) | (6,991) | — | (54,557) |
| Other items | (6,529) | 12,494 | (110) | 7,103 |
| Change in: | ||||
| Premiums receivable | (135,693) | (60,397) | 8,723 | (13,394) |
| Paid losses recoverable | (54,547) | (11,408) | (3,170) | (47,976) |
| Deferred acquisition costs | (41,748) | (16,323) | (2,739) | (40,735) |
| Prepaid reinsurance | (29,993) | (11,764) | (603) | 8,593 |
| Unpaid losses and loss adjustment expenses recoverable | 16,786 | (65,320) | 5,730 | (42,210) |
| Other assets | (42,669) | (41,894) | (21,457) | (14,855) |
| Reserve for losses and loss adjustment expenses | 173,762 | 440,784 | 36,464 | 324,399 |
| Unearned premiums | 193,034 | 96,733 | 461 | 141,465 |
| Reinsurance balances payable | 27,990 | (42,476) | (27,483) | (23,813) |
| Accounts payable and accrued expenses and other | 55,297 | (36,079) | (29,369) | 61,146 |
| Net cash provided by (used in) operating activities | 283,155 | 190,927 | (33,913) | 226,529 |
| Investing activities | ||||
| Proceeds from redemptions from Two Sigma Funds | 2,591,705 | 2,592,289 | 184,480 | 2,113,989 |
| Contributions to Two Sigma Funds | (2,554,888) | (2,464,902) | (137,453) | (1,870,057) |
| Net proceeds from sale of equity method investment | — | — | — | 57,428 |
| Purchases of fixed maturity investments | (1,221,576) | (705,144) | (54,445) | (655,693) |
| Proceeds from sales, redemptions and maturity of fixed maturity investments | 688,978 | 420,702 | 51,370 | 347,418 |
| Purchases of short-term investments | (1,506,241) | (1,551,834) | (357,857) | (2,035,529) |
| Proceeds from sales of short-term investments | 1,389,409 | 1,843,007 | 413,054 | 2,163,920 |
| Change in receivables for investments sold | (42,048) | (345) | 58,412 | 20,178 |
| Change in payables for investments purchased | 18,511 | 12,920 | (114,041) | 11,814 |
| Other | (15,938) | (13,591) | (432) | (15,644) |
| Net cash provided by (used in) investing activities | (652,088) | 133,102 | 43,088 | 137,824 |
| Financing activities | ||||
| Issuance of common shares | 73 | 7 | — | 5 |
| Repurchases of common shares and options | (2,435) | (1,518) | — | (7,380) |
| Contribution of additional paid-in capital | 82,924 | 308 | — | 1,008 |
| Term loan, net of issuance costs | — | (345) | — | — |
| Withdrawal of non-controlling interest | (21,546) | (68,069) | (23) | (61,629) |
| Net cash provided by (used in) financing activities | 59,016 | (69,617) | (23) | (67,996) |
| Effect of exchange rate changes on cash and cash equivalents | 3,574 | (11,335) | 46 | (1,508) |
| Net increase (decrease) in cash and cash equivalents | (306,343) | 243,077 | 9,198 | 294,849 |
| Cash and cash equivalents and restricted cash and cash equivalents, beginning of period | 1,207,203 | 964,126 | 954,928 | 660,079 |
| Cash and cash equivalents and restricted cash and cash equivalents, end of period | $900,860 | $1,207,203 | $964,126 | $954,928 |
| Net income taxes paid | $4,211 | $9,971 | $170 | $12,344 |
| Interest paid | $21,608 | $15,655 | $475 | $11,803 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.